20DCM Crystallization Purification via Ethyl Formate

The patent employs crystallization, a phase transition process, to purify 20DCM. The compound is dissolved in ethyl formate and then allowed to crystallize, forming pure crystalline structures that exclude impurities. This phase transition approach achieves high purity (>99.5%) without requiring time-consuming chromatographic steps, directly resolving the contradiction between purity and purification time.

The crystallization process selectively extracts pure 20DCM from the complex mixture of synthetic by-products and impurities. The crystalline structure formation inherently excludes contaminating compounds, effectively 'taking out' the desired pure compound from the contaminated reaction mixture without requiring multiple purification steps that would reduce yield.

The patent performs purification by crystallization immediately after synthesis, before prolonged storage can cause oxidation. This preliminary purification action removes potential oxidation products and prevents further degradation, ensuring high purity is maintained. The process addresses the contradiction by acting preemptively rather than dealing with oxidation damage after it occurs.

The crystallization process exploits subtle differences in molecular packing and solubility parameters between 20DCM and the 1α-hydroxyvitamin D4 contaminant. By controlling crystallization conditions (solvent choice, temperature, concentration), the process selectively crystallizes pure 20DCM while leaving the contaminant in the mother liquor, achieving reduction of impurity levels below detectable limits.